tiprankstipranks
Haemonetics narrows FY25 adjusted EPS view to $4.50-$4.70 from $4.45-$4.75
The Fly

Haemonetics narrows FY25 adjusted EPS view to $4.50-$4.70 from $4.45-$4.75

Consensus $4.59. Narrows FY25 adjusted operating margin to 24% from 23%-24%. Lowers FY25 free cash flow view to $120M-$140M from $130M-$180M.

Maximize Your Portfolio with Data Driven Insights:

  • Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
  • Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App